Multiple Myeloma: Sequencing Novel Therapies in Later Lines of Treatment
Focused discussion on the sequencing of bispecifics or CAR T-cell therapies in patients with multiply relapsed multiple myeloma.
Source: onclive.com
📰 Later Lines News
Later Lines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Later Lines. Real-time updates on events, politics, business and more.
T-DXd: 'Remarkable' Survival Gains in Advanced Breast Cancer
The antibody-drug conjugate trastuzumab deruxtecan continues to show impressive progression-free and overall survival gains in previously treated unresectable and/or metastatic HER2+ breast cancer.
Source: medscape.com